Table 1.
Percent of comorbid cases in COVID-19 positive cases.
| Comorbid disease | Percent reported | Patients population | Reference |
|---|---|---|---|
| Cerebrovascular diseases | 22% | 52 patients | (X. Yang et al., 2020) |
| Diabetes | 22% | ||
| Hypertension | 23·7% | 1099 patients | (W. Guan, Ni, et al., 2020) |
| Diabetes mellitus | 16·2% | ||
| Coronary heart diseases | 5·8% | ||
| Cerebrovascular disease | 2·3% | ||
| Hypertension | 30% | 140 patients | (Jin jin Zhang et al., 2020) |
| Diabetes | 12% | ||
| Case-fatality rate cardiovascular disease | 10.5% | 1023 deaths among 44,672 confirmed cases | (Z. Wu and McGoogan, 2020) |
| Diabetes | 7.3% | ||
| Chronic respiratory disease | 6.3% | ||
| Hypertension | 6.0% | ||
| Cancer | 5.6% | ||
| Diabetes | 8.9% | 146 patients | Fadini et al. (2020) |
| Diabetes | 8.2% | 1590 patients | (W. J. Guan et al., 2020) |
| Diabetes | 34.7%; 9.7% | 4103 patients (hospitalized vs non-hospitalized) | Petrilli et al. (2020) |
| Obesity | 39.5%; 30.8% | ||
| Diabetes | 24% | 258 patients | (Y. Zhang et al., 2020) |
| Diabetes | 9.8% | 16003 patients | Kumar et al. (2020) |
| Diabetes | 2.79% | 1382 patients | Roncon et al. (2020) |
| Diabetes | 19% | 191 patients | Zhou et al. (2020) |
| Diabetes | 13% | 7337 patients | (L. L. Zhu et al., 2020) |
| Diabetes | 25% | 193 patients | Yongli Yan et al. (2020) |
| Diabetes | 44% | 59 patients | Sardu et al. (2020) |
| Diabetes | 4.8% | 61414470 patients | Barron et al. (2020) |